7wmg - Revision history

OCA at 17:42, 29 November 2023

OCA — Wed, 29 Nov 2023 17:42:19 GMT

←Older revision		Revision as of 17:42, 29 November 2023
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[7wmg]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7WMG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7WMG FirstGlance]. <br>		<table><tr><td colspan='2'>[[7wmg]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7WMG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7WMG FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=9IF:2-[[1-methoxy-4-oxidanyl-7-(4-phenoxyphenoxy)isoquinolin-3-yl]carbonylamino]ethanoic+acid'>9IF</scene></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.93Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=9IF:2-[[1-methoxy-4-oxidanyl-7-(4-phenoxyphenoxy)isoquinolin-3-yl]carbonylamino]ethanoic+acid'>9IF</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7wmg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7wmg OCA], [https://pdbe.org/7wmg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7wmg RCSB], [https://www.ebi.ac.uk/pdbsum/7wmg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7wmg ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7wmg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7wmg OCA], [https://pdbe.org/7wmg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7wmg RCSB], [https://www.ebi.ac.uk/pdbsum/7wmg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7wmg ProSAT]</span></td></tr>
	</table>		</table>

OCA at 10:10, 21 December 2022

OCA — Wed, 21 Dec 2022 10:10:52 GMT

←Older revision		Revision as of 10:10, 21 December 2022
Line 1:		Line 1:

-	====	+	==A novel chemical derivative(52) of THRB agonist==
-	<StructureSection load='7wmg' size='340' side='right'caption='[[7wmg]]' scene=''>	+	<StructureSection load='7wmg' size='340' side='right'caption='[[7wmg]], [[Resolution\|resolution]] 2.93Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[7wmg]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7WMG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7WMG FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7wmg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7wmg OCA], [https://pdbe.org/7wmg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7wmg RCSB], [https://www.ebi.ac.uk/pdbsum/7wmg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7wmg ProSAT]</span></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=9IF:2-[[1-methoxy-4-oxidanyl-7-(4-phenoxyphenoxy)isoquinolin-3-yl]carbonylamino]ethanoic+acid'>9IF</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7wmg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7wmg OCA], [https://pdbe.org/7wmg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7wmg RCSB], [https://www.ebi.ac.uk/pdbsum/7wmg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7wmg ProSAT]</span></td></tr>
	</table>		</table>
		+	== Disease ==
		+	[https://www.uniprot.org/uniprot/THB_HUMAN THB_HUMAN] Defects in THRB are the cause of generalized thyroid hormone resistance (GTHR) [MIM:[https://omim.org/entry/188570 188570]. GTHR is a disease characterized by goiter, abnormal mental functions, increased susceptibility to infections, abnormal growth and bone maturation, tachycardia and deafness. Affected individuals may also have attention deficit-hyperactivity disorders (ADHD) and language difficulties. GTHR patients also have high levels of circulating thyroid hormones (T3-T4), with normal or slightly elevated thyroid stimulating hormone (TSH).<ref>PMID:2510172</ref> <ref>PMID:2153155</ref> <ref>PMID:1846005</ref> <ref>PMID:1661299</ref> <ref>PMID:1653889</ref> <ref>PMID:1563081</ref> <ref>PMID:1314846</ref> <ref>PMID:1619012</ref> <ref>PMID:1587388</ref> <ref>PMID:1324420</ref> <ref>PMID:8514853</ref> <ref>PMID:8175986</ref> <ref>PMID:7833659</ref> <ref>PMID:8664910</ref> <ref>PMID:8889584</ref> <ref>PMID:10660344</ref> <ref>PMID:16804041</ref> <ref>PMID:19268523</ref> Defects in THRB are the cause of generalized thyroid hormone resistance autosomal recessive (GTHRAR) [MIM:[https://omim.org/entry/274300 274300]. An autosomal recessive disorder characterized by goiter, clinical euthyroidism, end-organ unresponsiveness to thyroid hormone, abnormal growth and bone maturation, and deafness. Patients also have high levels of circulating thyroid hormones, with elevated thyroid stimulating hormone. Defects in THRB are the cause of selective pituitary thyroid hormone resistance (PRTH) [MIM:[https://omim.org/entry/145650 145650]; also known as familial hyperthyroidism due to inappropriate thyrotropin secretion. PRTH is a variant form of thyroid hormone resistance and is characterized by clinical hyperthyroidism, with elevated free thyroid hormones, but inappropriately normal serum TSH. Unlike GRTH, where the syndrome usually segregates with a dominant allele, the mode of inheritance in PRTH has not been established.<ref>PMID:7528740</ref> <ref>PMID:8381821</ref>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/THB_HUMAN THB_HUMAN] High affinity receptor for triiodothyronine.<ref>PMID:17418816</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	The design and development of agonists selectively targeting thyroid hormone receptor beta (TRbeta) and TRbeta mutants remain challenging tasks. In this study, we first adopted the strategy of breaking the "His-Phe switch" to solve two problems, simultaneously. A structure-based design approach was successfully utilized to obtain compound 16g, which is a potent TRbeta agonist (EC(50): 21.0 nM, 85.0% of the maximum efficacy of 1) with outstanding selectivity for TRbeta over TRalpha and also effectively activates the TRbeta(H435R) mutant. Then, we developed a highly efficient synthetic method for 16g. Our serials of cocrystal structures revealed detailed structural mechanisms in overcoming subtype selectivity and rescuing the H435R mutation. 16g also showed excellent lipid metabolism, safety, metabolic stability, and pharmacokinetic properties. Collectively, 16g is a well-characterized selective and mutation-sensitive TRbeta agonist for further investigating its function in treating dyslipidemia, nonalcoholic steatohepatitis (NASH), and resistance to thyroid hormone (RTH).
		+
		+	Discovery of a Highly Selective and H435R-Sensitive Thyroid Hormone Receptor beta Agonist.,Li Q, Yao B, Zhao S, Lu Z, Zhang Y, Xiang Q, Wu X, Yu H, Zhang C, Li J, Zhuang X, Wu D, Li Y, Xu Y J Med Chem. 2022 May 26;65(10):7193-7211. doi: 10.1021/acs.jmedchem.2c00144. Epub , 2022 May 4. PMID:35507418<ref>PMID:35507418</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 7wmg" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: ~~Z-disk~~]]	+	[[Category: Li Y]]
		+	[[Category: Yao BQ]]

OCA at 10:18, 18 May 2022

OCA — Wed, 18 May 2022 10:18:16 GMT

←Older revision		Revision as of 10:18, 18 May 2022
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 7wmg ~~is ON HOLD until Paper Publication~~	+	====
-		+	<StructureSection load='7wmg' size='340' side='right'caption='[[7wmg]]' scene=''>
-	~~Authors~~: ~~Yao, B~~.Q.~~, Li, Y~~.	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>
-	~~Description~~: ~~A novel chemical derivative(52) of THRB agonist~~	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7wmg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7wmg OCA], [https://pdbe.org/7wmg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7wmg RCSB], [https://www.ebi.ac.uk/pdbsum/7wmg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7wmg ProSAT]</span></td></tr>
-	[[~~Category~~: ~~Unreleased Structures~~]]	+	</table>
-	[[Category: ~~Li, Y~~]]	+	__TOC__
-	[[Category: ~~Yao, B.Q~~]]	+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Z-disk]]

OCA at 05:46, 2 February 2022

OCA — Wed, 02 Feb 2022 05:46:47 GMT

←Older revision		Revision as of 05:46, 2 February 2022
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 7wmg is ON HOLD	+	The entry 7wmg is ON HOLD until Paper Publication

	Authors: Yao, B.Q., Li, Y.		Authors: Yao, B.Q., Li, Y.

OCA: Protected "7wmg" [edit=sysop:move=sysop]

OCA — Thu, 27 Jan 2022 05:44:31 GMT

Protected "7wmg" [edit=sysop:move=sysop]

←Older revision

Revision as of 05:44, 27 January 2022

OCA: New page: '''Unreleased structure''' The entry 7wmg is ON HOLD Authors: Yao, B.Q., Li, Y. Description: A novel chemical derivative(52) of THRB agonist Category: Unreleased Structures [[Categ...

OCA — Thu, 27 Jan 2022 05:44:30 GMT

New page: '''Unreleased structure''' The entry 7wmg is ON HOLD Authors: Yao, B.Q., Li, Y. Description: A novel chemical derivative(52) of THRB agonist Category: Unreleased Structures [[Categ...

New page

'''Unreleased structure'''

The entry 7wmg is ON HOLD

Authors: Yao, B.Q., Li, Y.

Description: A novel chemical derivative(52) of THRB agonist
[[Category: Unreleased Structures]]
[[Category: Li, Y]]
[[Category: Yao, B.Q]]